204 related articles for article (PubMed ID: 8573219)
1. Identification of efonidipine hydrochloride metabolites in rats.
Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y
Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219
[TBL] [Abstract][Full Text] [Related]
2. Plasma and urinary metabolites of efonidipine hydrochloride in man.
Nakabeppu H; Asada M; Oda T; Shinozaki Y; Yajima T
Xenobiotica; 1996 Feb; 26(2):229-39. PubMed ID: 8868006
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs.
Takayama F; Iwasawa Y; Saito K; Shiratori K; Ohtawa M
Xenobiotica; 1989 Dec; 19(12):1407-20. PubMed ID: 2618091
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
Hirota T; Nakamura A; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of amlodipine. Identification and synthesis of metabolites found in rat, dog and human urine/confirmation of structures by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
Beresford AP; Macrae PV; Alker D; Kobylecki RJ
Arzneimittelforschung; 1989 Feb; 39(2):201-9. PubMed ID: 2525041
[TBL] [Abstract][Full Text] [Related]
8. Identification of benidipine hydrochloride metabolites in rats and dogs.
Kobayashi H; Okumura S; Kosaka Y; Kobayashi S; Inoue A; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1753-6. PubMed ID: 3219155
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of nifedipine in rat and dog.
Scherling D; Karl W; Radtke M; Ahr HJ; Siefert HM
Arzneimittelforschung; 1992 Nov; 42(11):1292-300. PubMed ID: 1492841
[TBL] [Abstract][Full Text] [Related]
10. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
Yabuki M; Shono F; Nakatsuka I; Yoshitake A
Drug Metab Dispos; 1993; 21(6):1167-9. PubMed ID: 7905400
[No Abstract] [Full Text] [Related]
11. In Vitro-In Vivo Correlation for Solid Dispersion of a Poorly Water-Soluble Drug Efonidipine Hydrochloride.
Cheng X; Gao J; Li J; Cheng G; Zou M; Piao H
AAPS PharmSciTech; 2020 May; 21(5):160. PubMed ID: 32476084
[TBL] [Abstract][Full Text] [Related]
12. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
13. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
14. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
15. Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method.
Huang S; Zhang Q; Li H; Sun Y; Cheng G; Zou M; Piao H
Eur J Pharm Biopharm; 2018 Sep; 130():108-114. PubMed ID: 29928981
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment.
Otsuka M; Maeno Y; Fukami T; Inoue M; Tagami T; Ozeki T
Eur J Pharm Biopharm; 2016 Nov; 108():25-31. PubMed ID: 27553261
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
[TBL] [Abstract][Full Text] [Related]
18. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
[TBL] [Abstract][Full Text] [Related]
19. Determination of efonidipine in human plasma by LC-MS/MS for pharmacokinetic applications.
Liu M; Zhao H; Tong Y; Zhang D; Wang X; Zhang L; Han J; Liu H
J Pharm Biomed Anal; 2015 Jan; 103():1-6. PubMed ID: 25462114
[TBL] [Abstract][Full Text] [Related]
20. Identification of new metabolites of morroniside produced by rat intestinal bacteria and HPLC-PDA analysis of metabolites in vivo.
Li X; Huo C; Wang Q; Zhang X; Sheng X; Zhang L
J Pharm Biomed Anal; 2007 Oct; 45(2):268-74. PubMed ID: 17707607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
